Previous close | 9.25 |
Open | 8.66 |
Bid | 0.00 x 0 |
Ask | 10.00 x 0 |
Day's range | 8.66 - 8.66 |
52-week range | 8.60 - 25.50 |
Volume | |
Avg. volume | 24,733 |
Market cap | 63.472M |
Beta (5Y monthly) | -0.17 |
PE ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
NEW YORK, NY, Jan. 17, 2024 (GLOBE NEWSWIRE) -- via NewMediaWire – EF Hutton, an investment bank headquartered in New York, today announced that the registration window is open for its Annual Global Conference taking place on May 15, 2024, at the Plaza Hotel in New York City, showcasing dynamic public and private companies across multiple sectors in an intimate setting. The EF Hutton Annual Global Conference features key executives from public and private companies conveying their unique stories
Accomplished healthcare and finance leader brings strategic experience and vision to Healthcare & Life Sciences Investment Banking Team NEW YORK, NY, Jan. 03, 2024 (GLOBE NEWSWIRE) -- via NewMediaWire -- EF Hutton, an investment bank headquartered in New York, today announced the appointment of David Sans, PhD, FAARM MBA, as Managing Director, Head of Healthcare, to lead the Company’s Healthcare & Life Sciences Investment Banking Team. David Sans, PhD, FAARM MBA, brings many years of biotech and
“When EF Hutton Talks, People Listen” NEW YORK, NY, Nov. 30, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire – EF Hutton, an investment bank headquartered in New York, today announced the closing of the acquisition of its broker-dealer, Benchmark Investments, LLC, a provider of a range of financial services to institutional and retail clients. The transaction closed on November 9, 2023, significantly expanding EF Hutton’s capabilities and leadership across public and private markets for its growing ro